These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15517419)

  • 1. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levamisole therapy in corticosteroid-dependent nephrotic syndrome.
    Bagga A; Sharma A; Srivastava RN
    Pediatr Nephrol; 1997 Aug; 11(4):415-7. PubMed ID: 9260236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
    Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B; Babu BG; Mahapatra TK
    Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ; Amon O; Timmermann K; Altrogge H; Müller-Wiefel DE
    Dtsch Med Wochenschr; 1998 Feb; 123(9):239-43. PubMed ID: 9524533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K; Müller-Berghaus J; Fuchshuber A; Michalk D; Querfeld U
    Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
    Hafeez F; Ahmed TM; Samina U
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):35-7. PubMed ID: 16441986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
    Fu LS; Chi CS
    Acta Paediatr Taiwan; 2000; 41(2):80-4. PubMed ID: 10927944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC;
    Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO; Kari JA
    Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study.
    Banerjee S; Sengupta J; Sinha R; Chatterjee S; Sarkar S; Akhtar S; Saha R; Pahari A
    Pediatr Nephrol; 2024 Oct; 39(10):2969-2977. PubMed ID: 38822220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
    Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S; Kalra S; Shukla S; Sharma P
    Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.
    Kuźma-Mroczkowska E; Skrzypczyk P; Pańczyk-Tomaszewska M
    Cent Eur J Immunol; 2016; 41(3):243-247. PubMed ID: 27833440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.